GlassScriptPhysician profile
Emily L Meyerhoffer
NPI 1073275434
$1,090.68
in general payments reported to CMS, 2019-2025
26 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $302 · 2024: $139 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.55 | 2022-2023 | |
| Organon LLC | $121.67 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $82.05 | 2022 | |
| Exeltis, USA INC. | $72.83 | 2023 | Slynd |
| Glaxosmithkline, LLC. | $70.11 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Daiichi Sankyo INC. | $65.33 | 2022-2023 | Injectafer |
| Phathom Pharmaceuticals, INC. | $58.28 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $42.93 | 2023-2025 | Wegovy |
| Pfizer INC. | $37.46 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.87 | 2025 | Farxiga, Airsupra |
| Bioventus LLC | $31.93 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Axsome Therapeutics, INC. | $30.02 | 2025 | Auvelity |
| Baxter Healthcare | $29.86 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $26.60 | 2025 | Evenity |
| Corium, LLC | $20.18 | 2025 | Azstarys |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $20.06 | 2025 | Sublocade |
| Dynavax Technologies Corporation | $20.01 | 2024 | Heplisav-B |
| Aimmune Therapeutics, INC. | $19.65 | 2025 | Vowst |
| Cranial Technologies, INC | $19.64 | 2025 | Doc Band |
| Sumitomo Pharma America, INC. | $19.30 | 2025 | Gemtesa |
| Evofem Biosciences, INC. | $18.92 | 2023 | Phexxi |
| Channel Medsystems, INC. | $17.81 | 2024 | |
| Biogen, INC. | $15.72 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.67 | 2025 | Xifaxan |
| Lilly USA, LLC | $14.50 | 2025 | Zepbound, Mounjaro |
| Coopersurgical, INC. | $12.73 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Meyerhoffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.